Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusion

Thrombosis and Haemostasis

Volumn 83, Issue 5, 2000, Pages 666-671

  Heymans, Stephane ^a   Vanderschueren, Steven ^b   Verhaeghe, Raymond ^b   Stockx, Luc ^b   Lacroix, Hendrik ^b   Nevelsteen, André ^b   Laroche, Yves ^a   Collen, Désiré ^a,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Peripheral vascular:disease; Plasminogen activators; Staphylokinase; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOGEN; HEPARIN; RECOMBINANT PROTEIN; STAPHYLOKINASE;

ADULT; AGED; ALLERGIC REACTION; AMPUTATION; ARTERY GRAFT; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BYPASS SURGERY; CHRONIC PAIN; CLAUDICATION; CLINICAL TRIAL; DIABETIC ANGIOPATHY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GANGRENE; GRAFT OCCLUSION; HUMAN; HYPERTENSION; ISCHEMIA; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; THORAX PAIN;

EID: 0034059219     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613889     Document Type: Article

References (18)

1. Ouriel K. Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH. Manzione JV, Cox C, Marder VJ. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19: 1021-30.
2. Weaver FA, Comerota AJ, Youngblood M, Froehlich J, Hosking JD. Papanicolaou G. Surgical revascularization versus thrombolysis for non-embolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg 1496; 24: 513-21.
3. Comerota AJ, Weaver FA, Hosking JD, Froehlich J, Folander H, Sussman B. Rosenfield K. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg 1996; 172: 105-12.
4. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998; 338: 1105-11.
5. Thrombolysis in the management of lower limb peripheral arterial occlusion a consensus document. Working Party on Thrombolysis in the Management of Limb Ischemia. Am J Cardiol 1998; 81: 207-18.
6. Collen D. Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agent. Nat Med 1998; 4: 279-84.
7. Vanderschueren S, Stockx L, Wilms G, Lacroix H, Verhaeghe R, Vermylen J, Collen D. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation 1995; 92: 2050-7.
8. Collen D, De Cock F, Stassen JM. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons. Circulation 1993; 87: 996-1006.
9. Collen D, Moreau H, Stockx L, Vanderschueren S. Recombinant staphylokinase varianls with altered immunoreactivity. II: Thrombolytic properties and antibody induction. Circulation 1996; 94: 207-16.
10. Collen D. Stockx L, Lacroix H. Suy R, Vanderschueren S. Recombinant staphylokinase variants with altered immunoreactivity. IV: Identification of variants with reduced antibody induction hut intact potency. Circulation 1997; 95: 463-72.
11. Greenberg RK, Ouriel K. A multi-modal approach to the management of bypass graft failure. Vasc Med 1998; 3: 215-20.
12. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg 1996: 23: 64-73.
13. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220: 251-66.
14. Collen D, Lijnen HR. Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? Blood 1994: 84: 680-6.
15. Lijnen HR, Van Hoef B, Vandenbossche L, Collen D. Biochemical properties of natural and recombinant staphylokinase. Fibrinolysis 1992; 6: 214-25.
16. Matas Docampo M, Gomez Palones F, Fernandez Valenzuela V. Segarra Medrano A, Moreiras Barreiro M. Intraarterial urokinase for acute native arterial occlusion of the limbs. Ann Vasc Surg 1997; 11: 565-72.
17. Vanderschueren S, Collen D. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models. Thromb Haemost 1996; 75: 816-9.
18. Vanderschueren S, Barrios L, Kerdsinchai P. Van den Heuvel P, Hermans L, Vrolix M, De Man F, Benit E, Muyldermans L, Collen D, Van de Werf F. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group. Circulation 1995; 92: 2044-9.